0001415889-24-003721.txt : 20240214 0001415889-24-003721.hdr.sgml : 20240214 20240214161521 ACCESSION NUMBER: 0001415889-24-003721 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191008 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN JEREMY M CENTRAL INDEX KEY: 0001256153 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 24638383 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 441 NINTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 4/A 1 form4a-02142024_040202.xml X0508 4/A 2019-10-08 2019-10-10 0001636651 Ovid Therapeutics Inc. OVID 0001256153 LEVIN JEREMY M C/O OVID THERAPEUTICS INC. 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 true true false false CEO 0 Common Stock 2019-09-20 4 G 0 465116 0 D 0 I See Footnote The shares were transferred to two family trusts for the benefit of the Reporting Person's adult children as part of generational estate planning. These transfers were made for no consideration. The Reporting Person does not serve as the trustee of the family trusts, nor does he maintain investment control over, or have a pecuniary interest in, the shares. These transactions are being reported late due to an inadvertent administrative error. Prior to the gift, the reportable securities were owned directly by DSL-EAL Holdings LLC (the "LLC"). The Reporting Person is the manager of the LLC. The Reporting Person may be deemed to share voting and investment powers for the shares held by the LLC. The Reporting Person disclaims beneficial ownership of the shares held by the LLC and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of any pecuniary interest therein. /s/ Danielle Mann for Jeremy M. Levin by POA 2024-02-14